We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
Cap. Flow
+$1.91B
Cap. Flow %
13.37%
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$139M
2
PG icon
Procter & Gamble
PG
+$118M
3
TFX icon
Teleflex
TFX
+$90.1M
4
MSFT icon
Microsoft
MSFT
+$89.4M
5
UBS icon
UBS Group
UBS
+$77.2M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$203M
2
AGN
Allergan plc
AGN
+$177M
3
MLNX
Mellanox Technologies, Ltd.
MLNX
+$118M
4
AMZN icon
Amazon
AMZN
+$115M
5
LIN icon
Linde
LIN
+$89.1M

Sector Composition

Rank Sector Weight
1 Healthcare 21.29%
2 Consumer Discretionary 15.87%
3 Technology 12.26%
4 Financials 12.01%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRMD icon
1376
TORM
TRMD
$3.1B
$236K ﹤0.01%
34,435
-1,722
-5% -$13.7K
LHCG
1377
DELISTED
LHC Group LLC
LHCG
$235K ﹤0.01%
+1,351
New +$198K
ATCXW
1378
DELISTED
Atlas Technical Consultants, Inc. Warrant
ATCXW
$234K ﹤0.01%
600,000
ACEL.WS
1379
DELISTED
Accel Entertainment Inc Warrant
ACEL.WS
$234K ﹤0.01%
99,997
CX icon
1380
Cemex
CX
$17.4B
$233K ﹤0.01%
+81,025
New +$190K
GWB
1381
DELISTED
Great Western Bancorp, Inc.
GWB
$231K ﹤0.01%
+16,777
New +$266K
BBVA icon
1382
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
$230K ﹤0.01%
+67,730
New +$213K
POR icon
1383
Portland General Electric
POR
$6.02B
$229K ﹤0.01%
+5,471
New +$251K
RYTM icon
1384
Rhythm Pharmaceuticals
RYTM
$7B
$229K ﹤0.01%
+10,257
New +$200K
TRMB icon
1385
Trimble
TRMB
$12.3B
$227K ﹤0.01%
5,252
-32,762
-86% -$1.23M
KURA icon
1386
Kura Oncology
KURA
$922M
$225K ﹤0.01%
+13,855
New +$200K
RPLA.WS
1387
DELISTED
Replay Acquisition Corp. Warrants
RPLA.WS
$225K ﹤0.01%
250,000
PGTI
1388
DELISTED
PGT, Inc.
PGTI
$224K ﹤0.01%
+14,291
New +$172K
AUTL
1389
Autolus Therapeutics
AUTL
$386M
$220K ﹤0.01%
13,672
-471,557
-97% -$5.23M
CPAAW
1390
DELISTED
Conyers Park II Acquisition Corp. Warrant
CPAAW
$220K ﹤0.01%
99,999
MOBL
1391
DELISTED
MobileIron, Inc.
MOBL
$220K ﹤0.01%
+44,476
New +$204K
IRTC icon
1392
iRhythm Holdings
IRTC
$3.59B
$219K ﹤0.01%
+1,888
New +$208K
ALE
1393
DELISTED
Allete
ALE
$218K ﹤0.01%
+3,994
New +$226K
MORN icon
1394
Morningstar
MORN
$6.56B
$218K ﹤0.01%
+1,546
New +$218K
OMCL icon
1395
Omnicell
OMCL
$1.86B
$218K ﹤0.01%
3,081
-4,752
-61% -$325K
SXC icon
1396
SunCoke Energy
SXC
$757M
$217K ﹤0.01%
+73,437
New +$235K
IWN icon
1397
iShares Russell 2000 Value ETF
IWN
$14.4B
$216K ﹤0.01%
+2,213
New +$201K
MD icon
1398
Pediatrix Medical
MD
$2.16B
$213K ﹤0.01%
12,473
+1,324
+12% +$19.6K
TYL icon
1399
Tyler Technologies
TYL
$12.2B
$212K ﹤0.01%
+611
New +$205K
CHMA
1400
DELISTED
Chiasma, Inc. Common Stock
CHMA
$212K ﹤0.01%
+39,327
New +$217K

Similar funds

Marshall Wace's Q2 2020 Portfolio in Review

As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.

  • Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
  • Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
  • Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
  • Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
  • Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
  • Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
  • Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.

Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.